Antibiotic Stewardship Intervention
BehavioralThe Antibiotic Stewardship Intervention will consist of education, motivating opinion leaders, adapting a pragmatic disease severity classification and prospective audit and feedback.
NCT Number: NCT02604628
The purpose of this study is to determine the effect of a multifaceted antibiotic stewardship intervention on protocol adherence of moderate-severe community-acquired pneumonia.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Noordwest Ziekenhuisgroep, Alkmaar, Netherlands
The purpose of the study is to show a decrease in broad-spectrum antibiotics with a non-inferiority in 90-day mortality. Hospitals with a pre-intervention protocol adherence of >70% are excluded from the primary analysis. Primary analysis will be done with a mixed effects model with a random effects for clusters and time. Crude outcomes and outcomes adjusted for potential confounders will be reported. Primary analysis will be tested one-sided for a decrease in mortality. Secondary analysis to test two-sided for mortality will be performed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Antibiotic Stewardship Intervention will consist of education, motivating opinion leaders, adapting a pragmatic disease severity classification and prospective audit and feedback.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Antibiotic use will be registered during hospital stay
Time frame: 90-days after hospital admission
All-cause mortality on day 90 from admission will be assessed from the municipal personal records database
Time frame: 30-days after hospital admission
All-cause mortality on day 30 from admission will be assessed from the municipal personal records database
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Clostridium difficile polymerase chain reaction (PCR) outcomes will be registered during hospital stay
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Complications of pneumonia during admission are registered from the clinical record
Time frame: Hospital readmissions within 30 days of hospital admission will be registered
Hospital readmissions will be registered 30 days after hospital admission
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Switches from intravenous to oral (and vice versa) and switches from broad-spectrum to narrow-spectrum (and vice versa) will be registered
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
Intensive Care admissions will be registered during hospital stay
UMC Utrecht
Other
Community-acquired Pneumonia: Increasing Protocol Adherence by Antibiotic Stewardship in a Stepped Wedge Cluster- Randomized Trial
Acronym: CAP-PACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05962606
Community-Acquired Infections, Community-Acquired Pneumonia
Birmingham, Alabama, United States
View Trial DetailsNCT05380193
Bacterial Infections, Bacterial Infections and Mycoses
Rennes, Brittany Region, France
View Trial DetailsNCT06263881
Community-Acquired Infections, Community-Acquired Pneumonia
Aramil, Russia
View Trial DetailsNCT04089787
Bacterial Infections, Bacterial Infections and Mycoses
Aalborg, Denmark
View Trial Details